Clinical Trial Update: Study of Topical SOR007 Ointment for Cutaneous Metastases [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 trial of topical SOR007 ointment for cutaneous metastases has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cutaneous Metastasis

Drugs mentioned

• SOR007

Snippet

Sponsor: NanOlogy, LLC | Conditions: Cutaneous Metastasis | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-11-04